HAVCR2 and cancer: Additionally, findings from a pan-cancer study revealed predominant expression of CXCR6 in PD1+TIM3+CD8+ terminally dysfunctional T-cells promoting their survival through the expression of Tox, Bcl2, and CX3CR1 (191).